AIM
BMRN icon

Assured Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Assured Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,689
Closed -$341K – 597
2016
Q3 		$341K Buy
+3,689
New +$347K 0.01% 465
2015
Q3 		– Sell
-459
Closed -$63K – 612
2015
Q2 		$63K Buy
+459
New +$56.9K ﹤0.01% 592
2015
Q1 		– Sell
-36,000
Closed -$3.25M – 574
2014
Q4 		$3.25M Sell
36,000
-24,800
-41% -$2.06M 0.06% 174
2014
Q3 		$4.39M Sell
60,800
-6,600
-10% -$434K 0.07% 156
2014
Q2 		$4.19M Buy
+67,400
New +$4.07M 0.07% 153

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return